Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects

被引:45
作者
Dohi, Yasuaki
Takase, Hiroyuki
Sato, Koichi
Ueda, Ryuzo
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Enshu Gen Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan
[3] Johoku Hosp, Dept Internal Med, Nagoya, Aichi, Japan
关键词
atherosclerosis; cardiovascular risk factor; inflammation; isoprostane;
D O I
10.1016/j.ijcard.2006.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Inflammation and oxidative stress play a key role in the pathogenesis of atherosclerosis. This study was designed to examine the interrelationships among C-reactive protein (CPP), oxidative stress, and traditional cardiovascular risk factors. Methods: We conducted a cross-sectional analysis among 551 apparently healthy Japanese subjects not receiving medication (mean age, 53 +/- 11 years; males/females, 400/151). Subject underwent laboratory assessment of cardiovascular disease risk factors, and CRP and 8-isoprostane, a marker of oxidative stress, were measured. Results: In unadjusted analyses, CRP was positively correlated with age, male gender, body mass index, blood pressure, smoking habit, creatinine, uric acid, triglycerides, an index of insulin resistance, and 8-isoprostane, and inversely correlated with high-density lipoprotein-cholesterol. 8-Isoprostane was positively correlated with age, pulse pressure, smoking habit, brain natriuretic peptide, and CRP. In multiple regression analyses, body mass index (r=0.177), high-density lipoprotein-cholesterol (r=-0.162), uric acid (r=0.141), and 8-isoprostane (r=0.097) were independently correlated with CRP (P < 0.001), whereas smoking (r=0.341), age (r=0.217), and pulse pressure (r=0.091) remained independently correlated with 8-isoprostane (P < 0.001). Conclusions: CRP levels are associated not only with clinical cardiovascular risk factors but also with oxidative stress. There are significant interrelationships among inflammation, oxidative stress, and traditional cardiovascular risk factors. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 26 条
[1]   Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women [J].
Bermudez, EA ;
Rifai, N ;
Buring, J ;
Manson, JE ;
Ridker, PA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1668-1673
[2]   Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease [J].
Bickel, C ;
Rupprecht, HJ ;
Blankenberg, S ;
Espiniola-Klein, C ;
Schlitt, A ;
Rippin, G ;
Hafner, G ;
Treude, R ;
Othman, H ;
Hofmann, KP ;
Meyer, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (08) :901-908
[3]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   Association of C-reactive protein with markers of prevalent atherosclerotic disease [J].
Folsom, AR ;
Pankow, JS ;
Tracy, RP ;
Arnett, DK ;
Peacock, JM ;
Hong, YL ;
Djoussé, L ;
Eckfeldt, JH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (02) :112-117
[6]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[7]  
Harrison D, 2003, AM J CARDIOL, V91, p7A
[8]   Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells [J].
Haug, C ;
Lenz, C ;
Bachern, MG .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 103 (03) :298-306
[9]   Prevalence of conventional risk factors in. patients with coronary heart disease [J].
Khot, UN ;
Khot, MB ;
Bajzer, CT ;
Sapp, SK ;
Ohman, EM ;
Brener, SJ ;
Ellis, SG ;
Lincoff, AM ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :898-904
[10]  
Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]